Lee Financial »

Taysha Gene Therapies shares owned by Lee Financial

Quarter-by-quarter ownership of Taysha Gene Therapies (TSHA) shares owned by Lee Financial from 13F filings

Historical chart of Lee Financial investment in Taysha Gene Therapies

Tip: Access up to 7 years of quarterly data

All positions including Taysha Gene Therapies held by Lee Financial consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Taysha Gene Therapies by Lee Financial

Quarter filed Position value Share count Share price at filing
2023-12-31 $35k 20k 1.77
2023-09-30 $63k 20k 3.16

More positions owned by Lee Financial

Ishares Tr Core S&p500 Etf (IVV)
Ishares Tr Core S&p Mcp Etf (IJH)
Schwab Strategic Tr Schwab Fdt Us Lg (FNDX)
Berkshire Hathaway Inc Del Cl B New (BRK.B)
First Tr Exchange-traded No Amer Energy (EMLP)
Ishares Tr Short Treas Bd (SHV)
Ishares Tr S&p 500 Grwt Etf (IVW)
Spdr Gold Tr Gold Shs (GLD)
Select Sector Spdr Tr Energy (XLE)
Apple (AAPL)
Ishares Tr Core S&p Scp Etf (IJR)
Ishares Tr Select Divid Etf (DVY)
Invesco Qqq Tr Unit Ser 1 (QQQ)
Schwab Strategic Tr Schwb Fdt Int Lg (FNDF)
Schwab Strategic Tr Us Mid-cap Etf (SCHM)

View all positions for Lee Financial

Top funds holding Taysha Gene Therapies

RA Capital Management
VR Adviser
Vanguard Group
venBio Select Advisor
Baker Bros. Advisors
Artal Group
Millennium Management
Point72 Asset Management
Citadel Advisors
Damian Sousa
Cowen And Company
Susquehanna International
T. Rowe Price Associates
Schonfeld Strategic Advisors
Quantum Private Wealth

View all funds holding Taysha Gene Therapies